F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea – The New York Times By Weight Loss F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The New York Times FDA approves weight loss drug Zepbound to treat obstructive sleep apnea NPR Lilly’s weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea Reuters Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest